glutathione reductase in caco-2 cells differentiated were treated with different factors, with Caco-2 [Caco2] - HTB-37 |

DynaPro Titan Plate Reade Page 208 and 209: A Abdel-Rehim, Mohamed 250-41P, 194 Page 210 and 211: Baldwin, Aaron 2970-7 Baldwin, Davi Page 212 and 213: Bronn, Marielle 810-1 Bronstein, Ig Page 214 and 215: Choi, Charles J 2920-3 Choi, Joo Yo Page 216 and 217: Denton, M Bonner 40-5, 1360-3, 2550 Page 218 and 219: Feng, Jun 1470-4 Feng, Lianmei 1650 Page 220 and 221: Gordon, Christopher 250-51P, 1130-2 Page 222 and 223: Heineman, William R 1400-4 Heinrich Page 224 and 225: Jackson, Abby Jo 210-4 Jackson, Aya Page 226 and 227: Kempfert, Kenneth D 2740-12P Kendha Page 228 and 229: Lawson, Stephen 930-10P, 1640- 21P, Page 230 and 231: Luna Vera, Fernando 1820-8 Lund, Ch Page 232 and 233: Mei-Lien, Chen 2690-1P Meighan, Mic Page 234 and 235: Nasse, Michael J 1560-4 Naushad, Mu Page 236 and 237: Parthasarathi, 600-15P Manigandan P Page 238 and 239: Rajendiran, 1690-9P Thekkelnaycke M Page 240 and 241: Samide, Michael J 100-5, 840-5P, 13 Page 242 and 243: Simon, Richard 570-1P Simpson, Gart Page 244 and 245: T Tabet, Jean-Claude 190-3 Tachikaw Page 246 and 247: Van der Walt, Stefanus 1340-5P Van Page 248 and 249: White, Christian 1240-2P, 1340-6P W Page 250 and 251: Yue, Hongfei 2090-3 Yuji, Sakoda 25 Page 252 and 253: V Session # Van Emon, Jeanette M 15 Page 254 and 255: ADVERTISERS Agilent Technologies

Food and Drug Administration issued a warning letter citing sterility failures, subpotent injectable and ophthalmic drugs, and insanitary production conditions at its Pennsylvania facility

Personalized Med Univ

doi: 10.1016/j.molmed.2010.03.003 138

2021 Epub ahead of print

Consistent with the result of patch assay, W303-1b/P provided a slightly higher GSH production than W303-1b/P and strain W303-1b in shake flask cultures (Fig